NATIONAL NEWS

2 new malaria treatments announced as drug resistance grows

Nov 12, 2025, 2:03 PM

This October 2024 image provided by Novartis shows GanLum, a new anti-malaria treatment, at a manuf...

This October 2024 image provided by Novartis shows GanLum, a new anti-malaria treatment, at a manufacturing facility in Slovenia. (Novartis via AP)
Credit: ASSOCIATED PRESS

(Novartis via AP)

NEW YORK (AP) — Researchers on Wednesday reported two promising new approaches to counteract malaria’s growing resistance to medication — one involving a new class of drugs.

Switzerland-based Novartis released results of what it called a next-generation treatment. A study of its experimental drug in 12 African countries found it works well against the mosquito-borne parasite that causes malaria and seems to block spread.

The drug, called GanLum, is not yet licensed and more than a year away from being available.

It’s needed, said Dr. David Sullivan, a malaria expert at Johns Hopkins University.

The parasite that causes the disease is developing resistance to existing drugs, meaning “the ice is thinning,” Sullivan said. “It hasn’t given way, but we’re concerned.”

GanLum has been given as a packet of tiny powder-like granules, once daily for three days. But getting people to take malaria drugs over several days has been challenging — some stop after one or two doses makes them feel better. Experts say a third or more of malaria patients fail to complete the current standard three-day treatment course, a problem that can encourage drug resistance and allow curable cases to intensify.

In an effort to offer a one-time treatment, another team of researchers said an experiment in West Africa found a single dose of four widely available malaria drugs proved to be an effective cure.

The two studies were presented Wednesday at the American Society of Tropical Medicine and Hygiene conference in Toronto.

Parasite has repeatedly developed drug resistance

Malaria is caused by a parasite that spreads through mosquito bites. Infected people can suffer fever, chills and flu-like illness that, if left untreated, can lead to severe complications and death. It’s mainly found in tropical and subtropical climates. The largest death toll in recent years has been seen in children in sub-Saharan Africa.

The medical battle against malaria has ebbed and flowed, as new drugs come along, but the parasite gradually develops the ability to resist them.

At the beginning of this century, for example, resistance to the drug chloroquine was widespread and malaria killed more than 1.8 million people per year. But then came a class of drugs known as artemisinins, which worked well and helped drive a dramatic decline in global malaria death rates.

Artemisinin-based compounds remain the first-line treatment in most cases. But signs of partial resistance have been reported, and — for several reasons — malaria death rates have plateaued or even started to rise in some parts of the world.

Study tested 4-drug combo

Dr. Ghyslain Mombo-Ngoma led a study in Gabon in which researchers gave a single-dose treatment combining an artemisinin with three other antimalarial medications — pyronaridine, sulfadoxine, and pyrimethamine.

From May 2024 to October 2025, he and his colleagues treated more than 1,000 patients, half of them younger than 10, who were sick with malaria but not suffering life-threatening symptoms. A little over half got the four-drug, one-time treatment. The rest got a standard, artemisinin-based treatment.

Blood tests 28 days later showed 93% of patients who received the one-time treatment were free of parasites compared with 90% who received the standard three-day course.

Mombo-Ngoma said there are discussions underway with a drug manufacturer to produce a single capsule or packet of pills to help create an inexpensive, easy-to-take cure.

Sullivan, however, noted that resistance is already established to some components of the treatment, meaning it likely will prove to be “a short-term fix.”

Experimental treatment shows promise

Novartis’ GanLum is a combination of a new drug, ganaplacide, and an existing long-acting medication, lumefantrine.

In a study involving about 1,700 adults and children in 12 African countries, GanLum was found to have a cure rate of better than 97%, which was a little higher than a common artemisinin-based treatment. It was also highly effective against mutant malaria parasites with partial drug resistance, Novartis officials said.

Side effects included fever and anemia — similar to what’s seen in patients who take some of the current antimalarials, Novartis officials said. There was a higher level of vomiting right after the drug was given, which company officials say may stem from its taste. The company is exploring flavoring or sweetening, a spokesman said.

Novartis officials said they are working toward regulatory approvals. George Jagoe of the Medicines for Malaria Venture, which collaborated with Novartis, said he hopes to see GanLum begin rolling out to patients within 18 months.

The new treatment approaches can complement other efforts against malaria, including treated mosquito bed nets and new vaccines, said Dr. Andrea Bosman, a malaria expert with the World Health Organization.

But the promising news comes at a time when funding from the United States and some other sources is being cut, which could impact the ability of scientists to monitor drug resistance or make prevention and treatments available to people who need them, Bosman noted.

“The eyes on the problem are going to be blinded” as aid to malaria-stricken countries declines, he said.

___

The Associated Press receives financial support from the Howard Hughes Medical Institute’s Department of Science Education, the Robert Wood Johnson Foundation and the Gates Foundation, among others. The AP is solely responsible for all content. Find AP’s standards for working with philanthropies, a list of supporters and funded coverage areas at AP.org.

Please follow our Community Guidelines

National News

People run as waves crash onto Beach Boulevard in Pacifica, Calif., Saturday, Nov. 14, 2026. (Steph...

Associated Press

Huge waves pummel the California coast, forcing the closure of iconic piers

SAN FRANCISCO (AP) — The California coast was pummeled again on Sunday by huge waves that inundated beaches, flooded local streets and forced the closure of iconic piers. The National Weather Service office for the Bay Area warned that surf up to 35 feet (10.6 meters) was possible, along with dangerous rip currents and sneaker […]

4 hours ago

Zariah Coleman, center left, and, Mossa Keita, center right, residents of the Brooklyn building tha...

Associated Press

Isaac, a cat missing since the Brooklyn building collapse, has been reunited with his young owner

NEW YORK (AP) — A cat missing since last week’s deadly Brooklyn building collapse has been found alive and reunited with his young owner, New York City officials said Sunday. Allie Taylor, director of the Mayor’s Office of Animal Welfare, said her office worked with the veterinary nonprofit Flatbush Cats to locate Isaac and reunite […]

4 hours ago

The American Heritage river cruise paddleboat is seen on its side after being struck by the Atlanti...

Associated Press

Officials say a tanker’s steering failed before it crashed into a cruise ship in New Orleans

A tanker’s steering system failed and kept its rudder in a position that sent it crashing into a cruise ship docked in New Orleans, U.S. government safety officials said Sunday. The preliminary finding from National Transportation Safety Board officials provided the first official word on what caused Friday’s crash of the Atlantic Asphalt tanker into […]

5 hours ago

FILE - People walk around Oxford University's campus on Sept. 3, 2017, in Oxford, England. (AP Phot...

Associated Press

32 Americans named as Rhodes scholars have variety of interests, from space junk to art history

WASHINGTON (AP) — A college senior who wants to clean up debris pollution in Earth’s orbit and a student who has researched AI use in healthcare are among the 32 Americans named as 2027 Rhodes scholars. The winners, who were announced on Saturday, have a variety of interests, from bioelectronics to water scarcity to art […]

7 hours ago

FILE - Vehicles drive past the entrance to Miami International Airport in Miami May 12, 2020, (AP P...

Associated Press

2 planes collide on the ground in Miami, only minor injuries reported

MIAMI (AP) — Federal aviation safety officials on Sunday were investigating a minor collision between two planes at a taxiway intersection at Miami International Airport, where one aircraft’s wingtip struck the nose of another, authorities said. Two people reported minor injuries. The accident happened at about 9 p.m. Saturday and involved a Copa Airlines Boeing […]

9 hours ago

The Washington Monument is seen as workers remove trees at East Potomac Park Golf Course, Monday, O...

Associated Press

Trump blasts judge’s 2-week halt to his Washington golf project and says administration will appeal

WASHINGTON (AP) — President Donald Trump on Sunday decried a “highly destructive and political decision” from a federal judge after she ordered a two-week delay on renovations at a historic Washington public golf course that he has been trying to redevelop into a championship-level venue. In a social media post, Trump said his administration will […]

12 hours ago

2 new malaria treatments announced as drug resistance grows